WHO ICTRP trial
A multicenter and randomized controlled clinical study on the treatment of…
ChiCTR1800016259 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800016259 |
|---|---|
| Public title | A multicenter and randomized controlled clinical study on the treatment of malignant pleural effusion with Endostar and/or Nedaplatin |
| Scientific title | A multicenter and randomized controlled clinical study on the treatment of malignant pleural effusion with Endostar and/or Nedaplatin |
| Primary sponsor | The First Affiliated Hospital of Guangxi Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | malignant pleural effusion |
| Interventions | Pleural cavity perfusion therapy with Endostar:Endostar;Pleural cavity perfusion therapy with Nedaplatin:Nedaplatin;Pleural cavity perfusion therapy with Endostar and Nedaplatin:Endostar and Nedaplatin |
| Registration date | May 22, 2018 |
| Target size | Pleural cavity perfusion therapy with Endostar:60;Pleural cavity perfusion… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: